Show all News

We are working to develop our technology and commercialise MSC-based pharmaceuticals – find out more about our day-to-day work.

More startups participating in the MIT Enterprise Forum Poland accelerator program. The technologies they have to offer are full of surprises!

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this by connecting these innovators with the know-how, experience and assets of leading corporations, investment funds as well as various other organizations from Poland and around the world. Nearly 100 startups have already received a much-needed boost from the accelerator program. Łukasz Owczarek, Head of Acceleration at the Technological Entrepreneurship Foundation which is organizing the program, says that there are still plenty of ground-breaking, youthful companies in Poland – players that absolutely have the potential to conquer foreign markets – provided they receive the right kind of support at the beginning of their journey.
Bioceltix: utilizing the immunomodulatory properties of stem cells in order to treat typical autoimmune conditions in animals. The company creates biopharmaceuticals which offer several advantages versus traditional pharmacology.

Wrote about us

Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.  These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not ...


Innowacje na start: Chivas Venture and Bioceltix

We hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for coverage of Chivas Ventures. The forth edition of this contest for startups that are socially involved has now come, gone and guess what? The jury ...


Another round of the prestigious contest designed for social-involved startups – Chivas Venture–  is behind us. We are among the five companies that, on January 17th 2019, will take part in the grand finale of the contest – which is happening in Warsaw. That mid-January ...


Łukasz Bzdzion talks biopharmaceuticals for animals on Polish Radio

The CEO of Bioceltix, Łukasz Bzdion, during an interview for Channel 4 of Polish Radio, answered question regarding the possibility of treating animals using stem-cell-baed biopharmaceuticals and more. The interview starts in the 37th minute.   


(Un)limited stem cells Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and ...